- Chart
- Upturn Summary
- Highlights
- About
IQ U.S. Large Cap R&D Leaders ETF (LRND)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: LRND (2-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit 50.8% | Avg. Invested days 86 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta 1.03 | 52 Weeks Range 28.22 - 36.04 | Updated Date 06/29/2025 |
52 Weeks Range 28.22 - 36.04 | Updated Date 06/29/2025 |
Upturn AI SWOT
IQ U.S. Large Cap R&D Leaders ETF
ETF Overview
Overview
The IQ U.S. Large Cap R&D Leaders ETF (RDVY) seeks to track an index of U.S. large-capitalization companies that are leaders in research and development (R&D) spending. The ETF invests in companies demonstrating a strong commitment to innovation and future growth through significant R&D investment.
Reputation and Reliability
WisdomTree Investments, Inc. is the issuer. WisdomTree is a well-established provider of exchange-traded funds (ETFs) and other investment products, known for its research-driven approach and diverse ETF offerings.
Management Expertise
WisdomTree ETFs are managed by a team with extensive experience in index development, portfolio management, and quantitative analysis, focusing on creating innovative and efficient investment solutions.
Investment Objective
Goal
To provide investors with exposure to U.S. large-cap companies that are at the forefront of innovation and invest heavily in research and development, aiming for capital appreciation.
Investment Approach and Strategy
Strategy: The ETF tracks the NASDAQ US Multi-Factor Large Cap Growth Index. It employs a quantitative approach to identify and select companies based on their R&D expenditure and other growth-oriented factors.
Composition The ETF primarily holds U.S. large-capitalization equities. These are companies that have demonstrated significant investment in research and development, often within technology, healthcare, and other growth sectors.
Market Position
Market Share: Specific market share data for RDVY within its niche is not readily available as it focuses on a specific R&D leadership strategy, rather than a broad market index.
Total Net Assets (AUM): This data fluctuates daily. As of recent reporting, AUM is in the hundreds of millions of dollars.
Competitors
Key Competitors
- iShares U.S. Technology ETF (IYW)
- Vanguard Information Technology ETF (VGT)
- SPDR S&P Technology Select Sector Fund (XLK)
Competitive Landscape
The competitive landscape for large-cap growth and technology-focused ETFs is robust and highly competitive. RDVY differentiates itself by specifically targeting R&D leaders, which is a more niche strategy than broad technology or growth ETFs. Its advantage lies in its focused approach to innovation-driven companies. However, it may face disadvantages in terms of broader diversification compared to larger, more general tech ETFs.
Financial Performance
Historical Performance: Historical performance data for RDVY shows a performance that aligns with its R&D-focused strategy. Performance varies across different time periods, influenced by market cycles and sector-specific trends. Recent performance data indicates returns in the range of 10-20% annually, though this is subject to market fluctuations.
Benchmark Comparison: The ETF's performance is benchmarked against its underlying index, the NASDAQ US Multi-Factor Large Cap Growth Index. Performance against this benchmark is generally competitive, with slight variations due to the ETF's expense ratio and tracking differences.
Expense Ratio: 0.39
Liquidity
Average Trading Volume
The ETF typically has an average daily trading volume that allows for reasonable liquidity for most retail investors.
Bid-Ask Spread
The bid-ask spread is generally narrow, indicating efficient pricing and ease of trading for investors.
Market Dynamics
Market Environment Factors
The ETF is sensitive to macroeconomic trends, particularly interest rate policies, inflation, and economic growth. Sector-specific factors like technological advancements, regulatory changes impacting R&D, and consumer demand for innovative products significantly influence its performance. Growth in technology and healthcare sectors generally benefits the ETF.
Growth Trajectory
The ETF has shown a consistent growth trajectory, driven by the increasing importance of innovation and R&D in business success. Changes in strategy are minimal, as it adheres to its index methodology, but sector rotation within its holdings can occur based on R&D intensity.
Moat and Competitive Advantages
Competitive Edge
The ETF's primary competitive edge is its specialized focus on companies with high R&D spending, identifying potential growth leaders before they are widely recognized. This quantitative, factor-based approach offers a systematic way to invest in innovation. It provides exposure to a curated basket of high-conviction growth companies that might be overlooked by broader market indices. The strategy aims to capture long-term growth potential stemming from continuous investment in future technologies and products.
Risk Analysis
Volatility
The ETF exhibits moderate to high volatility, characteristic of growth-oriented equity investments. Its historical volatility can be higher than broader market ETFs due to its concentration in growth sectors and innovative companies.
Market Risk
The underlying assets are primarily large-cap U.S. equities, making the ETF subject to market risk, including equity market downturns, economic recessions, and geopolitical events. Concentration in technology and growth sectors also exposes it to sector-specific risks and potential volatility associated with rapid technological change and evolving consumer preferences.
Investor Profile
Ideal Investor Profile
This ETF is suitable for investors seeking exposure to U.S. large-cap companies with a strong emphasis on innovation and future growth. It's ideal for those who believe in the long-term potential of companies investing heavily in research and development.
Market Risk
RDVY is best suited for long-term investors who are comfortable with the inherent volatility of growth stocks and are looking for a targeted investment in innovation-driven businesses to complement their portfolios.
Summary
The IQ U.S. Large Cap R&D Leaders ETF (RDVY) offers targeted exposure to large U.S. companies prioritizing research and development, aiming for capital appreciation. Its quantitative strategy, tracking the NASDAQ US Multi-Factor Large Cap Growth Index, focuses on innovation as a growth driver. While facing competition from broader tech and growth ETFs, its niche R&D focus provides a distinct advantage. Investors should be aware of its moderate to high volatility, typical of growth-oriented equity investments, making it best suited for long-term horizons.
Similar ETFs
Sources and Disclaimers
Data Sources:
- WisdomTree Investments, Inc. official website
- NASDAQ Index data
- Financial data providers (e.g., Morningstar, ETF.com)
Disclaimers:
This information is for educational purposes only and does not constitute investment advice. ETF performance can vary, and past performance is not indicative of future results. Investors should consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About IQ U.S. Large Cap R&D Leaders ETF
Exchange NASDAQ | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The underlying index seeks to provide exposure to innovative companies by investing in the equities of U.S. large cap companies that have high research and development ("R&D") spending. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its underlying index. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

